---
title: "Paige AI Review (2026) - Ratings, Output Quality & Pricing - AI Software Review"
name: "Paige AI"
slug: "paige-ai"
canonical_url: "https://www.aisoftwarereview.org/reviews/paige-ai/"
category: "AI Healthcare & Medical"
category_slug: "ai-healthcare-medical"
website_url: "https://paige.com"
pricing_model: "Enterprise"
starting_price: "Clinical Enterprise"
total_score: 8.2
tier: "Great"
ratings:
  output_quality: 8.5
  total_value: 8.0
  feature_depth: 8.4
  ease_of_use: 7.9
last_updated: "2026-03"
---

# Paige AI - AI Software Review & Benchmark

> **FDA-cleared AI pathology platform transforming cancer diagnostics from prostate to breast tissue.**

- **Composite Score:** **8.2 / 10** (Great)
- **Category:** [AI Healthcare & Medical](https://www.aisoftwarereview.org/categories/ai-healthcare-medical/)
- **Pricing:** Enterprise (Starting at Clinical Enterprise)
- **Official Website:** [https://paige.com](https://www.aisoftwarereview.org/r/paige-ai/)
- **Evaluated:** 2026-03 (Independent Review • Zero Pay-to-Play)

---

## Evaluation Scorecard

Our composite ratings weight real-world **Output Quality (35%)** and **Total Value (35%)** above venture hype.

| Evaluation Metric | Weight | Score | Description |
| :--- | :---: | :---: | :--- |
| **Output Quality** | **35%** | **8.5 / 10** | Accuracy, prompt adherence, coherence, and production readiness of outputs |
| **Total Value** | **35%** | **8.0 / 10** | Transparent pricing, unit economics, free tier utility, and ROI |
| **Feature Depth** | **15%** | **8.4 / 10** | Enterprise controls, API ecosystem, integrations, and workflow customization |
| **Ease of Use** | **15%** | **7.9 / 10** | UI responsiveness, onboarding ergonomics, documentation, and user friction |
| **Overall Composite Score** | **100%** | **8.2 / 10** | **Great** |

---

## Verdict & Editorial Summary

A groundbreaking FDA-cleared pioneer in AI-assisted digital pathology cancer diagnostics.

---

## Overview & Field Findings

Paige made history by receiving the first-ever FDA clearance for an AI in digital pathology (Paige Prostate), detecting microscopic cancerous foci on digital biopsy slides that humans might miss.

---

## Key Features & Capabilities

- First FDA-cleared AI tool in clinical pathology, assisting pathologists in diagnosing prostate cancer
- FullSlide AI architecture analyzing massive gigapixel digital pathology slide scans
- Seamless integration into digital pathology workflows and laboratory information systems

---

## Pricing & Commercial Terms

Enterprise annual subscriptions for hospital pathology departments and academic cancer institutes.


### Pricing Plans Breakdown

| Plan Name | Price | Billing Cycle | Highlights |
| :--- | :--- | :--- | :--- |
| **Paige Platform** | Enterprise | annual | First FDA-cleared AI in digital pathology; Paige Prostate diagnostic assist; Full digital slide viewer |


---

## Pros & Cons

### Strengths
- **+** Historical first FDA clearance in digital pathology
- **+** Detects tiny, easily overlooked cancerous cellular foci
- **+** Significantly reduces false-negative biopsy misdiagnoses

### Trade-offs & Limitations
- **-** Hospital pathology enterprise deployment only

---

## Deployment Recommendations

### Ideal For
- Hospital pathology departments, cancer laboratories, and academic medical centers

### Not Recommended For
- General non-medical consumers

---

*Published by AI Software Review ([www.aisoftwarereview.org](https://www.aisoftwarereview.org/)). All ratings are determined by standardized prompt testing without commercial compensation or pay-to-play sponsorships.*